Linked Life Data

19254918

Source:http://linkedlifedata.com/resource/pubmed/id/19254918

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2009-4-17
pubmed:abstractText
To evaluate the effectiveness and safety of adalimumab in treating patients with AS and advanced structural damage.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1462-0332
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
48
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
551-7
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
Adalimumab is effective and well tolerated in treating patients with ankylosing spondylitis who have advanced spinal fusion.
pubmed:affiliation
Medical Department I, Rheumatology, Charité, Campus Benjamin Franklin Hospital, Berlin, Germany. martin.rudwaleit@charite.de
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't, Multicenter Study